Quick Answer
SANGAMO THERAPEUTICS, INC reported Total Assets of $59.74 million for fiscal year 2025.
SANGAMO THERAPEUTICS, INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $59.74M | -41.2% |
| 2024 | $101.64M | -38.5% |
| 2023 | $165.32M | -70.6% |
| 2022 | $562.51M | -22.1% |
| 2021 | $721.92M | -23.1% |
| 2020 | $938.55M | +47.2% |
| 2019 | $637.52M | +8.0% |
| 2018 | $590.39M | +105.9% |
| 2017 | $286.74M | +81.6% |
| 2016 | $157.89M | -27.3% |
| 2015 | $217.24M | -10.7% |
| 2014 | $243.21M | +72.7% |
| 2013 | $140.84M | +70.6% |
| 2012 | $82.53M | -5.5% |
| 2011 | $87.34M | +38.6% |
| 2010 | $63.00M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $88.64M | -20.3% | -9.1% |
| June 30, 2025 | $97.56M | +4.9% | +13.2% |
| March 31, 2025 | $86.17M | -33.2% | -15.2% |
| December 31, 2024 | $101.64M | -38.5% | -8.7% |
| September 30, 2024 | $111.26M | -49.4% | +19.6% |
| June 30, 2024 | $93.01M | -71.4% | -27.9% |
| March 31, 2024 | $128.96M | -70.7% | -22.0% |
| December 31, 2023 | $165.32M | -70.6% | -24.8% |
- SANGAMO THERAPEUTICS, INC showed a decrease of -41.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, SANGAMO THERAPEUTICS, INC’s total assets has declined by 5.2% (from $63.00 million to $59.74 million).
- The most recent figure is from SANGAMO THERAPEUTICS, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: